secwatch.observer — SEC 8-K summary
======================================

Issuer:     NexImmune, Inc. (—)
CIK:        0001538210
Form:       8-K
Filed at:   2023-11-02T23:59:59+00:00
Accession:  0001193125-23-269417
Event type: regulatory
Sentiment:  positive
Materiality: 0.55
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

NexImmune regains Nasdaq minimum bid price compliance; delisting notice resolved
--------------------------------------------------------------------------------

- Received delisting notice on Oct 27, 2023 after second 180-day compliance period expired Oct 23.
- Regained compliance per Nasdaq notice dated Nov 1, 2023 following 1-for-25 reverse stock split effective Oct 18.
- Closing bid price has remained above $1.00 since reverse split; Nasdaq listing matter closed.
- Common stock continues trading on Nasdaq Capital Market under ticker NEXI.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1538210/000119312523269417/0001193125-23-269417-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1538210/000119312523269417/d576516d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-269417

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer